Integrated Clinical Science: Cardiology I – Anticlotting Drugs

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/25

flashcard set

Earn XP

Description and Tags

Question-and-answer flashcards summarizing mechanisms, examples, indications, and adverse effects of anticoagulants, antiplatelets, and thrombolytics discussed in the lecture.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

26 Terms

1
New cards

What are the three major classes of anticlotting ("blood-thinner") drugs?

Anticoagulants, antiplatelets, and thrombolytics.

2
New cards

Why are anticlotting drugs widely prescribed?

To prevent or treat clots in cardiovascular disease.

3
New cards

How does unfractionated heparin inhibit coagulation?

It binds antithrombin III, forming a complex that irreversibly inactivates thrombin and factor Xa.

4
New cards

What is the main mechanistic difference between unfractionated heparin and low-molecular-weight heparins (LMWHs)?

LMWHs (e.g., enoxaparin) predominantly inhibit factor Xa and have little direct effect on thrombin.

5
New cards

Name three common LMWH preparations.

Enoxaparin, dalteparin, tinzaparin.

6
New cards

List two major adverse effects of heparin therapy.

Bleeding and heparin-induced thrombocytopenia.

7
New cards

What is the mechanism of action of direct thrombin inhibitors (DTIs)?

They bind directly to the active site of thrombin, blocking its ability to convert fibrinogen to fibrin.

8
New cards

Give four examples of direct thrombin inhibitors.

Lepirudin, desirudin, bivalirudin, argatroban.

9
New cards

What is the primary toxicity shared by all direct thrombin inhibitors?

Increased risk of bleeding.

10
New cards

How do direct oral factor Xa inhibitors work?

They directly and reversibly bind to factor Xa, preventing the conversion of prothrombin to thrombin.

11
New cards

List four direct oral factor Xa inhibitors.

Rivaroxaban, apixaban, edoxaban, betrixaban.

12
New cards

Explain warfarin’s mechanism of action.

It inhibits vitamin K epoxide reductase.

13
New cards

Why is warfarin unsuitable for emergency anticoagulation?

Its onset is slow because pre-existing clotting factors must degrade.

14
New cards

Identify three important adverse effects or cautions with warfarin.

Bleeding, numerous CYP450 drug interactions, and teratogenicity.

15
New cards

Which class of drugs is used when a clot has already formed and must be rapidly lysed?

Thrombolytics.

16
New cards

Describe the mechanism of tissue plasminogen activator (tPA).

tPA converts plasminogen to plasmin.

17
New cards

Name three recombinant tPA drugs.

Alteplase, reteplase, tenecteplase.

18
New cards

How does streptokinase differ from tPA mechanistically?

Streptokinase forms a complex with plasminogen, causing a conformational change.

19
New cards

What immune-related problem can reduce streptokinase efficacy?

Anti-streptokinase antibody formation.

20
New cards

How does aspirin act as an antiplatelet agent?

Irreversibly inhibits COX-1, blocking thromboxane A2 synthesis.

21
New cards

State the mechanism and give two examples of glycoprotein IIb/IIIa inhibitors.

They reversibly block GP IIb/IIIa receptors, preventing platelet cross-linking; examples: abciximab, eptifibatide, tirofiban.

22
New cards

What are common side effects of GP IIb/IIIa receptor inhibitors?

Bleeding and antibody-mediated thrombocytopenia.

23
New cards

How do P2Y12 (ADP) receptor antagonists prevent thrombosis?

They inhibit ADP-mediated activation of P2Y12 receptors on platelets.

24
New cards

Name three P2Y12 receptor antagonists.

Clopidogrel, prasugrel, ticlopidine.

25
New cards

Explain the anticoagulant mechanism of PDE3 inhibitors.

They inhibit phosphodiesterase 3 and adenosine reuptake to raise platelet cAMP.

26
New cards

Which vitamin can be administered to facilitate clotting in deficiency states?

Vitamin K (restores synthesis of vitamin-K–dependent clotting factors).